Curriculum vitae kentaro Hayashida, md, PhD, fesc

Yüklə 198,24 Kb.

Pdf görüntüsü

tarix	02.10.2018
ölçüsü	198,24 Kb.
	#71708

CURRICULUM VITAE

Kentaro Hayashida, MD, PhD, FESC

Assistant Professor

Director, Transcatheter Heart Valve program

Director, Cardiac Catheterization Laboratory

Department of Cardiology, Keio University School of Medicine

35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan

Phone: +81358436702

FAX: +81353633875

e-mail: k-hayashida@umin.ac.jp

DATE and PLACE OF BIRTH:

October, 1975 Tokyo, Japan

NATIONALITY:

Japanese

EDUCATION:

2000.4 MD, Keio University School of Medicine, Tokyo, Japan

2006.4 PhD in Cardiology, Keio University School of Medicine, Tokyo, Japan

PROFESSIONAL ASSOCIATION:

•

Japanese Circulation Society

•

Japanese Society of Internal Medicine

•

Japanese Association of Cardiovascular Intervention and Therapeutics

•

Japanese Heart Failure Society

•

European Society of Cardiology (FESC)

AWARDS and HONORS:

2004.11 Cardiopulmonary Best Abstract Award, American Heart Association

Scientific Session 2004

2008.03 Young Investigators Award (2

degree), American College of Cardiology

2008

2009.10 Research award from Banyu fellowship program

2012.03 Young Investigators Award, American College of Cardiology 2012

2012.08 Best poster award, European Society of Cardiology 2012

LICENSURE and BOARD STATUS:

2000

Physician’s License in Japan

2003

Board Certified Member of the Japanese Society of Internal Medicine

2006

Fellow of the Japanese Society of Internal Medicine

2006

Board Certified Member of the Japanese Circulation Society

2007

Board Certified Member of the Japanese Society of Interventional Cardiology

2012

Board Certified Member of the Japanese Association of Cardiovascular

Intervention and Therapeutics

2012

A proctor for transfemoral-TAVI for Edwards Lifesciences

2013

Fellow of the European Society of Cardiology

RESEARCH and PROFESSIONAL EXPERIENCE:

2000-2001 Resident, Department of Internal Medicine, Keio University School of

Medicine, Tokyo, Japan

2000-2003 Post-graduate school student, Department of Cardiology, Keio University

School of Medicine, Tokyo, Japan

2004.4-

Fellow, Department of Cardiology, Keio University School of Medicine,

Tokyo, Japan

2004.6- Physician, Department of Cardiology, Ashikaga Red Cross Hospital,

Tochigi, Japan.

2007.7-

Assistant professor, associate director of cardiac catheterization laboratory,

Department of Cardiology, Keio University School of Medicine, Tokyo,

Japan

2009.4-

Assistant professor, director of cardiac catheterization laboratory, Division

of Cardiology, Department of Second Internal Medicine, Kyorin University

School of Medicine, Tokyo, Japan

2009.10- Fellow of Interventional Cardiology, Institut Cardiovausulaire Paris Sud,

Massy, France

2012.12- Assistant professor and lecturer, Director of transcatheter heart valve

program, co-director of cardiac catheterization laboratory, Department of

Cardiology, Keio University School of Medicine, Tokyo, Japan

2016.4-

Assistant professor and lecturer, Director of transcatheter heart valve

program, Director of cardiac catheterization laboratory, Department of

Cardiology, Keio University School of Medicine, Tokyo, Japan

JOURNAL REVIEW:

AsiaIntervention, associate editor

Circulation journal, editorial board

Circulation: Cardiovascular Interventions

JACC

JACC: Cardiovascular Interventions

EuroIntervention

Catheterization and cardiovascular interventions

Cardiovascular Intervention and Therapeutics

European Heart Journal

Heart

International Journal of Cardiology

American Journal of Cardiovascular Drugs

SCIENTIFIC COMMITTEE, FACULTY POSITIONS:

International

PCR Tokyo valves, Course Director

PCR London valves, International Course Co-Director

Asia PCR, Course Co-Director

PCR-CIT China Chengdu valves, programme committee member

EuroPCR, Faculty

TVT, Faculty

TCT, Faculty

AP valves, Course Co-Director

TCTAP, Faculty

ENCORE Seoul, Faculty

Complex Cardiovascular Therapeutics, SHD course, Course Director

Tokyo Percutaneous Cardiovascular Intervention Conference, Course Co-director

Domestic

Toyohashi live demonstration, Program committee member and organizer

Kamakura live demonstration, Faculty

Kokura live demonstration, Faculty

Japanese Heart Failure Society, Member of device committee

JTVT, Faculty

JHVD, Faculty

PUBLICATIONS:

Tamamori-Adachi M, Ito H, Nobori K, Hayashida K, Kawauchi J, Adachi S, Ikeda

MA, Kitajima S. Expression of cyclin D1 and CDK4 causes hypertrophic growth of

cardiomyocytes in culture: a possible implication for cardiac hypertrophy. Biochem

Biophys Res Commun. 2002 Aug 16;296(2):274-80.

Tamamori-Adachi M*, Hayashida K*, Nobori K, Kawauchi J, Omizu C, Kamura T,

Fukuda K, Ogawa S, Nakayama K, and Kitajima S. Down-regulation of p27Kip1

promotes cell proliferation of rat neonatal cardiomyocytes induced by nuclear

expression of cyclin D1 and CDK4. Evidence for impaired Skp2-dependent

degradation of p27 in terminal differentiation. J Biol Chem. 2004 Nov

26;279(48):50429-36. (* contributed equally to this paper)

3.

Hayashida K*, Fujita J*, Miyake Y, Kawada H, Yagi T, Ogawa S, Fukuda K. Bone

marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-

induced pulmonary hypertension. Chest 2005;127:1793-1798. (* contributed equally

to this paper)

Endo J, Sano M, Fujita J, Hayashida K, Yuasa S, Aoyama N, Takehara Y, Kato O,

Makino S, Ogawa S, Fukuda K. Bone Marrow–Derived Cells Are Involved in the

Pathogenesis of Cardiac Hypertrophy in Response to Pressure Overload. Circulation

2007 Sep 4;116(10):1176-84

Hayashida K, Sano M, Ohsawa I, Shinmura K, Tamaki K, Kimura K, Endo J,

Katayama T, Kawamura A, Kohsaka S, Makino S, Ohta S, Ogawa S, Fukuda K.

Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial

ischemia-reperfusion injury. Biochem Biophys Res Commun 2008 Aug 15;373(1):30-

Tokudome S, Sano M, Shinmura K, Matsuhashi T, Morizane S, Moriyama H, Tamaki

K, Hayashida K, Nakanishi H, Yoshikawa N, Shimizu N, Endo J, Katayama T,

Murata M, Yuasa S, Kaneda R, Tomita K, Eguchi N, Urade Y, Asano K, Utsunomiya

Y, Suzuki T, Taguchi R, Tanaka H, Fukuda K. Glucocorticoid protects rodent hearts

from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D

synthase–derived PGD

biosynthesis. J Clin Invest. 2009 Jun;119(6):1477-88

Suzuki Y, Sano M, Hayashida K, Ohsawa I, Ohta S, Fukuda K. Are the effects of

alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of

hydrogen gas in the gastrointestinal tract? FEBS Lett. 2009 Jul 7;583(13):2157-9.

Ueno K, Kawamura A, Onizuka T, Kawakami T, Nagatomo Y, Hayashida K, Yuasa

S, Maekawa Y, Anzai T, Jinzaki M, Kuribayashi S, Ogawa S. Effect of preoperative

evaluation by multidetector computed tomography in percutaneous coronary

interventions of chronic total occlusions. Int J Cardiol. 2012; 156(1):76-9

Hayashida K, Louvard Y, Lefèvre T. Transradial complex coronary interventions

using a five-in-six system. Catheter Cardiovasc Interv. 2011 Jan 1;77(1):63-8

10.

Hovasse T, Lefèvre T, Morice MC, Chevalier B, Hayashida K, Garot P, Romano M,

Donzeau-Gouge P, Farge A, Bouvier E, Cormier B. Percutaneous aortic valve

implantation: Results and perspectives. Presse Med. 2011 July - August;40(7-8):732-

739.

11.

Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D,

Uribe J, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC.

Transfemoral Aortic Valve Implantation: New Criteria to Predict Vascular

Complications. JACC Cardiovasc Interv. 2011 Aug;4(8):851-8.

12.

Hayashida K, Lefèvre T. Transcatheter Aortic Valve Implantation: New Hope for

Inoperable and High-risk Patients. Aortic stenosis Book 1. ISBN 978-953-308-86-0.

2011.

13.

Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D,

Uribe J, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC. True

percutaneous approach for transfemoral aortic valve implantation using Prostar XL

device. Impact of learning curve on vascular complications. JACC Cardiovasc Interv.

2012 Feb;5(2):207-14.

14.

Hayashida K, Morice MC, Chevalier B, Hovasse T, Romano M, Garot P, Farge A,

Donzeau-Gouge P, Bouvier E, Cormier B, Lefèvre T. Sex Differences in Clinical

Presentation and Outcome of Transcatheter Aortic Valve Implantation for Severe

Aortic Stenosis. J Am Coll Cardiol. 2012 Feb;59(6):566-71.

15.

Hayashida K, Bouvier E, Lefèvre T, Hovasse T, Morice MC, Chevalier B, Romano

M, Garot P, Farge A, Donzeau-Gouge P, Cormier B. Potential mechanism of annulus

rupture during transcatheter aortic valve implantation. Catheter Cardiovasc

Interv. 2013 Nov 1;82(5):E742-6.

16.

Hayashida K, Bouvier E, Lefèvre T, Hovasse T, Morice MC, Chevalier B, Romano

M, Garot P, Farge A, Donzeau-Gouge P, Cormier B. Impact of CT-guided valve

sizing on post-procedural aortic regurgitation in transcatheter aortic valve implantation.

EuroIntervention. 2012 8(5):546-55.

17.

Hayashida K, Bouvier E, Lefèvre T Successful management of annulus rupture in

transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2013 6(1):90-1

18.

Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P, Farge A,

Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC. Impact of post-procedural

aortic regurgitation on mortality after transcatheter aortic valve implantation. JACC

Cardiovasc Interv. 2012 5(12):1247-56

19.

Hayashida K, Lefèvre T. Treatment and prevention of aortic regurgitation after

transcatheter aortic valve implantation. EuroIntervention, 2012 ;8:Q34-Q40

20.

Kataoka M, Inami T, Hayashida K, Shimura N, Ishiguro H, Abe T, Tamura Y, Ando

M, Fukuda K, Yoshino H, Satoh T. Percutaneous Transluminal Pulmonary

Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension.

Circ Cardiovasc Interv. 5(6):756-62.

21.

Watanabe Y, Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P,

Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC. Is EuroSCORE II

better than EuroSCORE in predicting mortality after transcatheter aortic valve

implantation? Catheter Cardiovasc Interv. 2013 May;81(6):1053-60.

22.

Yamamoto M, Hayashida K, Mouillet G, Chevalier B, Meguro K, Watanabe Y,

Dubois-Rande JL, Morice MC, Lefevre T, Teiger E. Renal function based contrast

dosing predicts acute kidney injury following transcatheter aortic valve implantation.

JACC Cardiovasc Interv. 2013 May;6(5):479-86

23.

Hayashida K, Romano M, Lefèvre T, Chevalier B, Farge A, Hovasse T, Le Houérou

D, Morice MC. The Transaortic Approach for Transcatheter Aortic Valve

Implantation. A Valid Alternative to the Transapical Access in Patients with No

Peripheral Vascular Option. A Single Center Experience. Eur J Cardiothorac Surg.

2013 Oct;44(4):692-700.

24.

Hayashida K, Bouvier E, Lefèvre T, Hovasse T, Morice MC, Chevalier B, Romano

M, Garot P, Farge A, Donzeau-Gouge P, Cormier B. Transcatheter aortic valve

implantation for patients with severe bicuspid aortic valve stenosis. Circ Cardiovasc

Interv. 2013 Jun 1;6(3):284-91.

25.

Yamamoto M, Hayashida K, Mouillet G, Hovasse T, Chevalier B, Oguri A,

Watanabe Y, Dubois-Rande JL, Morice MC, Lefevre T, Teiger E.

Prognostic value of

chronic kidney disease after transcatheter aortic valve implantation

J Am Coll Cardiol.

2013 Sep 3;62(10):869-77.

26.

Watanabe Y, Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P,

Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC. Transcatheter aortic

valve implantation in patients of small body size. Catheter Cardiovasc Interv. 2013

Apr 24. doi: 10.1002/ccd.24970. [Epub ahead of print]

27.

Watanabe Y, Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P,

Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC.

Transfemoral Aortic

Valve Implantation in Patients with an Annulus Dimension Suitable for either the

Edwards Valve or the CoreValve.

Am J Cardiol. 2013 Sep 1;112(5):707-13.

28.

Watanabe Y, Morice MC, Bouvier E, Leong T, Hayashida K, Lefèvre T, Hovasse T,

Romano M, Chevalier B , Farge A, Donzeau-Gouge P, Cormier B, Garot P.

Automated 3-dimensional aortic annular assessment by multidetector computed

tomography in transcatheter aortic valve implantation. JACC Cardiovasc Interv.

Sep;6(9):955-64.

29.

Mogi S, Maekawa Y, Kodaira M, Anzai A, Arai T, Kawakami T, Hayashida K,

Yuasa S, Kawamura A, Fukuda K. Aortic aneurysm: an independent predictor of a

looped brachiocephalic trunk in patients undergoing transradial coronary angiography.

Coron Artery Dis. 2013 Nov;24(7):602-5.

30.

Maekawa Y, Jinzaki M, Tsuruta H, Yamada Y, Kishino Y, Kawakami T, Hayashida

K, Yuasa S, Murata M, Kawamura A, Sano M, Kuribayashi S, Fukuda K.

Multidetector computed tomography-guided percutaneous transluminal septal

myocardial ablation in a Noonan syndrome patient with hypertrophic obstructive

cardiomyopathy. Int J Cardiol. 2014 Mar 1;172(1):e79-81.

31.

Anzai A, Maekawa Y, Kodaira M, Mogi S, Arai T, Kawakami T, Kanazawa H,

Hayashida K, Yuasa S, Kawamura A, Fukuda K. Prognostic implications of optimal

medical therapy in patients undergoing percutaneous coronary intervention for acute

coronary syndrome in octogenarians. Heart Vessels. 2014 Feb 4. [Epub ahead of

print]

32.

Watanabe Y, Hayashida K, Lefevre T, Romano M, Hovasse T, Chevalier B, Garot P,

Donzeau-Gouge P, Farge A, Bouvier E, Cormier B, Morice MC. Is post dilatation

useful after implantation of the Edwards valve? Catheter Cardiovasc Interv. 2014

Mar 21. doi: 10.1002/ccd.25486. [Epub ahead of print]

33.

Shirakawa K, Egashira T, Ieda M, Kawaguchi S, Okamoto K, udo M, Yokoyama K,

Tsuruta H, Murata M, Mikami S, Anzai A, Hayashida K, Kohno T, Maekawa Y,

Sano M, Yozu R, Fukuda K. Multidisciplinary approach to the treatment of cardiac

AA amyloidosis and aortic stenosis due to Castleman's disease: a hybrid therapy with

tocilizumab and aortic valve replacement. Int J Cardiol. 2014 May 1;173(2):e9-e11.

doi: 10.1016/j.ijcard.2014.03.054. Epub 2014 Mar 16.

34.

Maekawa Y, Jinzaki M, Anzai A, Matsumura K, Tsuruta H, Kawakami T, Hayashida

K, Yuasa S, Murata M, Suzuki M, Kuribayashi S, Fukuda K. Utility of the reverse

wire technique in multidetector computed tomography-guided percutaneous

transluminal septal myocardial ablation. Int J Cardiol. 2014 May 15;173(3):e33-4.

doi: 10.1016/j.ijcard.2014.03.057. Epub 2014 Mar 18.

35.

Egashira T, Yuasa S, Kimura M, Sawano M, Anzai A, Hayashida K, Kawamura A,

Kimura T, Nishiyama N, Aizawa Y, Takatsuki S, Tsuruta H, Murata M, Yamada Y,

Kohno T, Maekawa Y, Sano M, Kosaki K, Fukuda K. Coexistence of two distinct

fascinating cardiovascular disorders: heterotaxy syndrome with left ventricular non-

compaction and vasospastic angina. Int J Cardiol. 2014 Jun 15;174(2):e54-6. doi:

10.1016/j.ijcard.2014.04.032. Epub 2014 Apr 15.

36.

Anzai A, Yuasa S, Kanazawa H, Kodaira M, Arai T, Kawakami T, Hayashida K,

Maekawa Y, Kawamura A, Fukuda K. "Phantom vessel" running parallel to the culprit

artery in a case of acute myocardial infarction. JACC Cardiovasc Interv. 2014

Jun;7(6):e51-2. doi: 10.1016/j.jcin.2013.08.020. Epub 2014 May 14.

37.

Watanabe Y, Hayashida K, Takayama M, Mitsudo K, Nanto S, Takanashi S, Komiya

T, Kuratani T, Tobaru T, Goto T, Lefèvre T, Sawa Y, Morice MC. First direct

comparison of clinical outcomes between European and Asian cohorts in transcatheter

aortic valve implantation: The Massy study group vs. the PREVAIL JAPAN trial. J

Cardiol. 2014 Jun 10. pii: S0914-5087(14)00146-4. doi: 10.1016/j.jjcc.2014.05.001.

38.

Inohara T, Hayashida K, Fukuda K. Double balloon aortic valvuloplasty in TAVI era:

insight from intracardiac echocardiography and multidetector computed tomography

findings. J Invasive Cardiol. 2014 Jul;26(7):E95-7.

39.

Maekawa Y, Jinzaki M, Anzai A, Tsuruta H, Matsumura K, Yamada Y, Tabei R,

Kawakami T, Hayashida K, Yuasa S, Murata M, Suzuki M, Kuribayashi S, Fukuda K.

Successful second attempt multidetector computed tomography-guided percutaneous

transluminal septal myocardial ablation for an octogenarian with hypertrophic

obstructive cardiomyopathy. Int J Cardiol. 2014 Oct 20;176(3):e131-2.

40.

Watanabe Y, Lefèvre T, Arai T, Hayashida K, Bouvier E, Hovasse T, Romano M,

Chevalier B, Garot P, Donzeau-Gouge P, Farge A, Cormier B, Morice MC. Can we

predict post-procedural paravalvular leak after Edwards Sapien transcatheter aortic

valve implantation? Catheter Cardiovasc Interv. 2014 Sep 9.

41.

Inohara T, Kohsaka S, Miyata H, Ueda I, Ishikawa S, Ohki T, Nishi Y, Hayashida K,

Maekawa Y, Kawamura A, Higashi T, Fukuda K. Appropriateness Ratings of

Percutaneous Coronary Intervention in Japan and Its Association With the Trend of

Noninvasive Testing. JACC Cardiovasc Interv. 2014 Sep;7(9):1000-9.

42.

Inohara T, Kohsaka S, Miyata H, Ueda I, Noma S, Suzuki M, Negishi K, Endo A,

Nishi Y, Hayashida K, Maekawa Y, Kawamura A, Higashi T, Fukuda K.

Appropriateness of coronary interventions in Japan by the US and Japanese standards.

Am Heart J. 2014 Dec;168(6):854-861.e11.

43.

Tsugu T, Murata M, Kawakami T, Yasuda R, Tokuda H, Minakata Y, Tamura Y,

Kataoka M, Hayashida K, Tsuruta H, Maekawa Y, Inoue S, Fukuda K. Significance

of echocardiographic assessment for right ventricular function after balloon

pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary

hypertension. Am J Cardiol. 2015 Jan 15;115(2):256-61

44.

Yamamoto M, Hayashida K, Watanabe Y, Mouillet G, Hovasse T, Chevalier B,

Oguri A, Dubois-Randé JL, Morice MC, Lefèvre T, Teiger E. Am J Cardiol. 2015 Jan

15;115(2):227-33. Effect of Body Mass Index <20 kg/m(2) on Events in Patients Who

Underwent Transcatheter Aortic Valve Replacement.

45.

Maekawa Y, Jinzaki M, Tsuruta H, Akita K, Yamada Y, Kawakami T, Hayashida K,

Yuasa S, Murata M, Fukuda K. Improved renal function in a patient with hypertrophic

obstructive cardiomyopathy after multidetector computed tomography-guided

percutaneous transluminal septal myocardial ablation. Int J Cardiol. 2014 Dec

24;181C:349-350.

46.

Watanabe Y, Chevalier B, Hayashida K, Leong T, Bouvier E, Arai T, Farge A,

Hovasse T, Garot P, Cormier B, Morice MC, Lefèvre T. Comparison of multislice

computed tomography findings between bicuspid and tricuspid aortic valves before

and after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2015

Jan 9. doi: 10.1002/ccd.25830.

47.

Inohara T, Hayashida K, Yashima F, Maekawa Y, Shimizu H, Fukuda K. "Dual role"

guiding catheter: a new technique for patients requiring coronary protection during

transcatheter aortic valve implantation. Cardiovasc Interv Ther. 2015 Mar 12.

48.

Inohara T, Kohsaka S, Abe T, Miyata H, Numasawa Y, Ueda I, Nishi Y, Naito K,

Shibata M, Hayashida K, Maekawa Y, Kawamura A, Sato Y, Fukuda K.

Development and validation of a pre-percutaneous coronary intervention risk model of

contrast-induced acute kidney injury with an integer scoring system. Am J Cardiol.

2015 Jun 15;115(12):1636-42.

49.

Watanabe Y, Lefèvre T, Bouvier E, Arai T, Hayashida K, Chevalier B, Romano M,

Hovasse T, Garot P, Donzeau-Gouge P, Farge A, Cormier B, Morice MC. Prognostic

value of aortic root calcification volume on clinical outcomes after transcatheter

balloon-expandable aortic valve implantation. Catheter Cardiovasc Interv. 2015 May

50.

Arai T, Lefèvre T, Hayashida K, Watanabe Y, O'Connor SA, Hovasse T, Romano M,

Garot P, Bouvier E, Chevalier B, Morice MC. Usefulness of a Simple Clinical Risk

Prediction Method, Modified ACEF Score, for Transcatheter Aortic Valve

Implantation. Circ J. 2015;79(7):1496-503.

51.

Yashima F, Hayashida K, Fukuda K. Delivery balloon-induced ascending aortic

dissection: An unusual complication during transcatheter aortic valve implantation.

Catheter Cardiovasc Interv. 2015 May 11.

52.

Watanabe Y, Chevalier B, Hayashida K, Leong T, Bouvier E, Arai T, Farge A,

Hovasse T, Garot P, Cormier B, Morice MC, Lefèvre T. Rebuttal: Comparison of

multislice computed tomography findings between bicuspid and tricuspid aortic valves

before and after transcatheter aortic valve implantation. Catheter Cardiovasc Interv.

2015 May 29.

53.

Takamatsu M, Hirotani T, Ohtsubo S, Saito S, Takeuchi S, Hasegawa T, Endo A,

Yamasaki Y, Hayashida K. [Aortic Valve Replacement after Balloon Valvuloplasty

for Aortic Valve Stenosis in a Dialysis Patient with Cardiogenic Shock;Report of a

Case]. Kyobu Geka. 2015 Jun;68(6):460-4.

54.

Inohara T, Kawakami T, Kataoka M, Yamamoto M, Kimura M, Kanazawa H, Yuasa

S, Hayashida K, Maekawa Y, Fukuda K. Lesion morphological classification by

OCT to predict therapeutic efficacy after balloon pulmonary angioplasty in CTEPH.

Int J Cardiol. 2015 Oct 15;197:23-5.

55.

Inohara T, Kohsaka S, Miyata H, Ueda I, Hayashida K, Maekawa Y, Kawamura A,

Numasawa Y, Suzuki M, Noma S, Nishi Y, Fukuda K. Real-World Use and

Appropriateness of Coronary Interventions for Chronic Total Occlusion (from a

Japanese Multicenter Registry). Am J Cardiol. 2015 Sep 15;116(6):858-64.

56.

Fujita J, Kohsaka S, Ueda I, Inohara T, Maekawa Y, Kawamura A, Kanazawa H,

Hayashida K, Tabei R, Tohyama S, Seki T, Suzuki M, Sano M, Fukuda K. The

Prevalence of Clinically Significant Ischemia in Patients Undergoing Percutaneous

Coronary Intervention: A Report from the Multicenter Registry. PLoS One. 2015 Jul

31;10(7):e0133568.

57.

Akita K, Maekawa Y, Tsuruta H, Okuda S, Yanagisawa R, Kageyama T, Kawakami T,

Kanazawa H, Hayashida K, Yuasa S, Murata M, Jinzaki M, Fukuda K. "Moving left

ventricular obstruction" due to stress cardiomyopathy in a patient with hypertrophic

obstructive cardiomyopathy treated with percutaneous transluminal septal myocardial

ablation. Int J Cardiol. 2015 Aug 25;202:194-195.

58.

Inohara T, Hayashida K, Watanabe Y, Yamamoto M, Takagi K, Yashima F, Arai T,

Shimizu H, Chevalier B, Lefèvre T, Fukuda K, Morice MC. Streamlining the learning

process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the

massy registries. Catheter Cardiovasc Interv. 2015 Oct 22. doi: 10.1002/ccd.26266.

[Epub ahead of print]

59.

Maekawa Y, Akita K, Tsuruta H, Yashima F, Kimura M, Yamada Y, Kawakami T,

Kanazawa H, Hayashida K, Yuasa S, Murata M, Jinzaki M, Fukuda K. "Protruding

Myocardium" as a Target for Percutaneous Transluminal Septal Myocardial Ablation

in a Case of Hypertrophic Obstructive Cardiomyopathy. JACC Cardiovasc Interv.

2015 Oct;8(12):e201-2.

60.

Arai T, Lefèvre T, Hovasse T, Hayashida K, Watanabe Y, O'Connor SA, Benamer H,

Garot P, Cormier B, Bouvier E, Morice MC, Chevalier B. Evaluation of the learning

curve for transcatheter aortic valve implantation via the transfemoral approach. Int J

Cardiol. 2015 Oct 26;203:491-497.

61.

Fukui S, Kawakami M, Otaka Y, Ishikawa A, Mizuno K, Tsuji T, Hayashida K,

Inohara T, Yashima F, Liu M. Physical frailty in older people with severe aortic

stenosis. Aging Clin Exp Res. 2015 Dec 7.

62.

Yashima F, Yuasa S, Maekawa Y, Kimura M, Akita K, Yanagisawa R, Tanaka M,

Hayashida K, Kawakami T, Kanazawa H, Fujita J, Fukuda K. In-Stent Dissection

Causes No Flow During Percutaneous Coronary Intervention. JACC Cardiovasc

Interv. 2015 Dec 8. pii: S1936-8798(15)01578-2. doi: 10.1016/j.jcin.2015.09.025.

63.

Isobe S, Ieda M, Kohno T, Nishiyama T, Maekawa Y, Tsuruta H, Murata M, Yashima

F, Yanagisawa R, Tanaka M, Inami S, Nasuno T, Haruyama A, Sano M, Hayashida

K, Fukuda K. Effective Cibenzoline Treatment in a Patient With Midventricular

Obstruction After Transcatheter Aortic Valve Implantation. Circ Heart Fail. 2016

Jan;9(1):e002629. doi: 10.1161/CIRCHEARTFAILURE.115.002629. Epub 2015 Dec

64.

Oda T, Okamura T, Miyazaki Y, Nakamura T, Mikamo A, Wada Y, Yamashita A,

Takahashi M, Hayashida K, Hamano K, Yano M. 1-Year Follow-Up of Contained

Aortic Root Rupture After Transcatheter Aortic Valve Replacement. JACC

Cardiovasc Interv. 2016 Feb 8;9(3):295-6. doi: 10.1016/j.jcin.2015.10.037. Epub

2016 Jan 6.

65.

Kanazawa H, Kawamura A, Kimura M, Akita K, Yashima F, Arai T, Kawakami T,

Hayashida K, Tsuruta H, Yuasa S, Itabashi Y, Murata M, Maekawa Y, Fukuda K.

JACC Cardiovasc Interv. 2016 Feb 25. pii: S1936-8798(15)01970-6. doi:

10.1016/j.jcin.2015.12.016.

66.

Sukegawa H, Maekawa Y, Yuasa S, Anzai A, Kodaira M, Takei M, Sano F, Ueda I,

Kawakami T, Hayashida K, Kohno T, Kohsaka S, Abe T, Fukuda K. Intensive statin

therapy stabilizes C-reactive protein, but not chemokine in stable coronary artery

disease treated with an everolimus-eluting stent. Coron Artery Dis. 2016 Apr 21.

67.

Kitahara H, Yoshitake A, Okamoto K, Hayashida K, Fukuda K, Shimizu H. Modified

transiliac artery approach for transcatheter aortic valve implantation. Cardiovasc

Interv Ther. 2016 Apr 22.

68.

Yoon SH, Ahn JM, Hayashida K, Watanabe Y, Shirai S, Kao HL, Yin WH, Lee MK,

Tay E, Araki M, Yamanaka F, Arai T, Lin MS, Park JB, Park DW, Kang SJ, Lee SW,

Kim YH, Lee CW, Park SW, Muramatsu T, Hanyu M, Kozuma K, Kim HS, Saito S,

Park SJ; Asian TAVR Investigators. Clinical Outcomes Following

Transcatheter Aortic Valve Replacement in Asian Population. JACC Cardiovasc

Interv. 2016 May 9;9(9):926-33. doi: 10.1016/j.jcin.2016.01.047.

69.

Yamamoto M, Shimura T, Kano S, Kagase A, Kodama A, Koyama Y, Watanabe Y,

Tada N, Takagi K, Araki M, Shirai S, Hayashida K. Impact of preparatory coronary

protection in patients at high anatomical risk of acute coronary obstruction during

transcatheter aortic valve implantation. Int J Cardiol. 2016 May 4;217:58-63. doi:

10.1016/j.ijcard.2016.04.185.

70.

Hayashida K. [Valvular Heart Disease: Current Treatment and Future Perspectives.

Topics: III. Current Treatment: Surgical vs. Medical; 1. Aortic valve, 2) Transcatheter

aortic valve implantation]. Nihon Naika Gakkai Zasshi. 2016 Feb 10;105(2):215-21.

71.

Arai T, Lefèvre T, Hovasse T, Morice MC, Garot P, Benamer H, Unterseeh T,

Hayashida K, Watanabe Y, Bouvier E, Cormier B, Chevalier B. Comparison of

Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve

implantation: Difference of valve selection in the real world. J Cardiol. 2016 Jun 7

72.

Maekawa Y, Akita K, Tsuruta H, Yamada Y, Hayashida K, Yuasa S, Murata M,

Jinzaki M, Fukuda K. Significant reduction of left atrial volume concomitant with

clinical improvement after percutaneous transluminal septal myocardial ablation for

drug-refractory hypertrophic obstructive cardiomyopathy, and its precise detection

with multidetector CT. Open Heart. 2016 Jun 3;3(1):e000359.

73.

Watanabe Y, Kozuma K, Hioki H, Kawashima H, Nara Y, Kataoka A, Shirai S, Tada

N, Araki M, Takagi K, Yamanaka F, Yamamoto M, Hayashida K. Comparison of

Results of Transcatheter Aortic Valve Implantation in Patients With Versus Without

Active Cancer. Am J Cardiol. 2016 May 28.

74.

Yashima F, Yamamoto M, Watanabe Y, Takagi K, Yamada Y, Inohara T,

Yanagisawa R, Tanaka M, Arai T, Shimizu H, Jinzaki M, Kozuma K, Fukuda K,

Suzuki T, Hayashida K. Impact of underfilling and overfilling in balloon-expandable

transcatheter aortic valve implantation assessed by multidetector computed

tomography: Insights from the Optimized CathEter vAlvular iNtervention (OCEAN-

TAVI) registry. Int J Cardiol. 2016 Jul 29;222:738-744. doi:

10.1016/j.ijcard.2016.07.218.

75.

Hioki H, Watanabe Y, Kozuma K, Nara Y, Kawashima H, Kataoka A, Yamamoto M,

Takagi K, Araki M, Tada N, Shirai S, Yamanaka F, Hayashida K; And on behalf of

OCEAN-TAVI investigators. Pre-procedural dual antiplatelet therapy in patients

undergoing transcatheter aortic valve implantation increases risk of bleeding. Heart.

2016 Aug 18. pii: heartjnl-2016-309735. doi: 10.1136/heartjnl-2016-309735.

76.

Matsumoto S, Yamada Y, Hashimoto M, Okamura T, Yamada M, Yashima F,

Hayashida K, Fukuda K, Jinzaki M. CT imaging before transcatheter aortic valve

implantation (TAVI) using variable helical pitch scanning and its diagnostic

performance for coronary artery disease. Eur Radiol. 2016 Aug 25. [Epub ahead of

print]

77.

Codner P, Levi A, Gargiulo G, Praz F, Hayashida K, Watanabe Y, Mylotte D, Debry

N, Barbanti M, Lefèvre T, Modine T, Bosmans J, Windecker S, Barbash I, Sinning JM,

Nickenig G, Barsheshet A, Kornowski R. Impact of Renal Dysfunction on Results of

Transcatheter Aortic Valve Replacement Outcomes in a Large Multicenter Cohort.

Am J Cardiol. 2016 Sep 15

78.

Kawashima H, Watanabe Y, Kozuma K, Nara Y, Hioki H, Kataoka A, Yamamoto M,

Takagi K, Araki M, Tada N, Shirai S, Yamanaka F, Hayashida K. Kawashima H,

Watanabe Y, Kozuma K, Nara Y, Hioki H, Kataoka A, Yamamoto M, Takagi K,

Araki M, Tada N, Shirai S, Yamanaka F, Hayashida K. EuroIntervention. 2016 Dec

20. EuroIntervention. 2016 Dec 20.

79.

Kodama A, Yamamoto M, Shimura T, Kagase A, Koyama Y, Tada N, Takagi K,

Araki M, Yamanaka F, Shirai S, Watanabe Y, Hayashida K. Comparative data of

single versus double proglide vascular preclose technique after percutaneous

transfemoral transcatheter aortic valve implantation from the optimized catheter

valvular intervention (OCEAN-TAVI) japanese multicenter registry. Catheter

Cardiovasc Interv. 2016 Oct 27.

80.

Watanabe Y, Kozuma K, Hioki H, Kawashima H, Nara Y, Kataoka A, Nagura F,

Nakashima M, Shirai S, Tada N, Araki M, Takagi K, Yamanaka F, Yamamoto M,

Hayashida K. Pre-Existing Right Bundle Branch Block Increases Risk for Death

After Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve.

JACC Cardiovasc Interv. 2016 Nov 14;9(21):2210-2216.

81.

Nishiyama T, Tanosaki S, Tanaka M, Yanagisawa R, Yashima F, Kimura T, Arai T,

Tsuruta H, Murata M, Aizawa Y, Kohno T, Maekawa Y, Hayashida K, Takatsuki S,

Fukuda K. Predictive factor and clinical consequence of left bundle-branch block after

a transcatheter aortic valve implantation. Int J Cardiol. 2016 Nov 9;227:25-29.

82.

Arai T, Yashima F, Yanagisawa R, Tanaka M, Shimizu H, Fukuda K, Watanabe Y,

Naganuma T, Araki M, Tada N, Yamanaka F, Shirai S, Yamamoto M, Hayashida K;

OCEAN-TAVI investigators. Prognostic value of liver dysfunction assessed by

MELD-XI scoring system in patients undergoing transcatheter aortic valve

implantation. Int J Cardiol. 2016 Nov 10;228:648-653.

83.

Arai T, Romano M, Lefèvre T, Hovasse T, Farge A, Le Houerou D, Hayashida K,

Watanabe Y, Garot P, Benamer H, Unterseeh T, Bouvier E, Morice MC, Chevalier B.

Direct Comparison of Feasibility and Safety of Transfemoral Versus

Transaortic Versus Transapical Transcatheter Aortic Valve Replacement. JACC

Cardiovasc Interv. 2016 Nov 28;9(22):2320-2325.

84.

Nara Y, Watanabe Y, Kozuma K, Kataoka A, Nakashima M, Hioki H, Kawashima H,

Nagura F, Shirai S, Tada N, Araki M, Naganuma T, Yamanaka F, Yamamoto M,

Hayashida K. Incidence, Predictors, and Mid-Term Outcomes of Percutaneous

Closure Failure After Transfemoral Aortic Valve Implantation Using an Expandable

Sheath (from the Optimized Transcatheter Valvular Intervention [OCEAN-TAVI]

Registry). Am J Cardiol. 2016 Nov 16.

85.

Yamamoto M, Shimura T, Kano S, Kagase A, Kodama A, Sago M, Tsunaki T,

Koyama Y, Tada N, Yamanaka F, Naganuma T, Araki M, Shirai S, Watanabe Y,

Hayashida K. Prognostic Value of Hypoalbuminemia After Transcatheter Aortic

Valve Implantation (from the Japanese Multicenter OCEAN-TAVI Registry). Am J

Cardiol. 2016 Dec 2.

86.

Yanagisawa R, Hayashida K, Yamada Y, Tanaka M, Yashima F, Inohara T, Arai T,

Kawakami T, Maekawa Y, Tsuruta H, Itabashi Y, Murata M, Sano M, Okamoto K,

Yoshitake A, Shimizu H, Jinzaki M, Fukuda K. Incidence, Predictors, and Mid-Term

Outcomes of Possible Leaflet Thrombosis After TAVR. JACC Cardiovasc Imaging.

2016 Dec 8.

87.

Shiraishi Y, Kohsaka S, Ueda I, Inohara T, Sawano M, Numasawa Y, Hayashida K,

Maekawa Y, Momiyama Y, Fukuda K. Degree of dyspnoea in patients with non-ST-

elevation acute coronary syndrome: A report from Japanese multicenter registry. Int J

Clin Pract. 2016 Dec;70(12):978-987

88.

Yanagisawa R, Kataoka M, Kitakata H, Kohno T, Maekawa Y, Hayashida K, Fukuda

K. Transcatheter Aortic Valve Implantation in a Patient with Severe, Precapillary

Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2017 Jan;14(1):147-149.

89.

Fukuoka R, Kohno T, Kohsaka S, Yanagisawa R, Kawakami T, Hayashida K,

Kanazawa H, Yuasa S, Maekawa Y, Sano M, Fukuda K. Nocturnal intermittent

hypoxia and short sleep duration are independently associated with elevated C-

reactive protein levels in patients with coronary artery disease. Sleep Med. 2017

Jan;29:29-34.

90.

Kakefuda Y, Hayashida K, Yamada Y, Yashima F, Inohara T, Yanagisawa R,

Tanaka M, Arai T, Kawakami T, Maekawa Y, Tsuruta H, Itabashi Y, Murata M, Sano

M, Okamoto K, Yoshitake A, Shimizu H, Jinzaki M, Fukuda K. Impact of Subclinical

Vascular Complications Detected by Systematic Postprocedural Multidetector

Computed Tomography After Transcatheter Aortic Valve Implantation Using

Balloon-Expandable Edwards SAPIEN XT Heart Valve. Am J Cardiol. 2017 Jan 5.

91.

Arai T, Lefèvre T, Hovasse T, Morice MC, Romano M, Benamer H, Garot P,

Hayashida K, Bouvier E, Chevalier B. The feasibility of transcatheter aortic valve

implantation using the Edwards SAPIEN 3 for patients with severe bicuspid aortic

stenosis. J Cardiol. 2017 Feb 10. pii: S0914-5087(17)30003-5. doi:

10.1016/j.jjcc.2016.12.009.

92.

Ikemura N, Sawano M, Shiraishi Y, Ueda I, Miyata H, Numasawa Y, Noma S, Suzuki

M, Momiyama Y, Inohara T, Hayashida K, Yuasa S, Maekawa Y, Fukuda K,

Kohsaka S.

Barriers Associated With Door-to-Balloon Delay in Contemporary Japanese Practice.

Circ J. 2017 Feb 23. doi: 10.1253/circj.CJ-16-0905.

93.

Arai T, Lefèvre T, Hovasse T, Garot P, Benamer H, Unterseeh T, Roy AK, Romano

M, Hayashida K, Watanabe Y, Bouvier E, Morice MC, Chevalier B. Incidence and

predictors of coronary obstruction following transcatheter aortic valve implantation in

the real world. Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26982.

94.

Shimura T, Yamamoto M, Kano S, Kagase A, Kodama A, Koyama Y, Tsuchikane E,

Suzuki T, Otsuka T, Kohsaka S, Tada N, Yamanaka F, Naganuma T, Araki M, Shirai

S, Watanabe Y, Hayashida K; on the behalf of OCEAN-TAVR investigators. Impact

of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve

Replacement. Circulation. 2017 Mar 16. pii: CIRCULATIONAHA.116.025630. doi:

10.1161/CIRCULATIONAHA.116.025630.

95.

Naganuma T, Kawamoto H, Takagi K, Yabushita H, Mitomo S, Watanabe Y, Shirai S,

Araki M, Tada N, Yamanaka F, Yamamoto M, Onishi H, Nakamura S, Higashimori A,

Tabata M, Mizutani K, Ueno H, Hayashida K. Can we perform rotational

atherectomy in patients with severe aortic stenosis? Substudy from the OCEAN TAVI

Registry. Cardiovasc Revasc Med. 2017 Feb 28. pii: S1553-8389(17)30058-1.

96.

Hayashida K, Yasuda S, Matsumoto T, Amaki M, Mizuno S, Tobaru T, Jujo K,

Ootomo T, Yamaguchi J, Fukuda K, Saito S, Foster E, Qasim A, Yozu R, Takayama

M. AVJ-514 Trial

- Baseline Characteristics and 30-Day Outcomes Following

MitraClip® Treatment in a Japanese Cohort. Circ J. 2017 Mar 17. doi:

10.1253/circj.CJ-17-0115.

97.

Yanagisawa R, Hayashida K, Jinzaki M, Fukuda K. Spontaneous Regression of

Possible Transcatheter Aortic Valve Thrombosis Without Additional Anticoagulant:

Two-Year Follow-Up. J Invasive Cardiol. 2017 May;29(5):E64

98.

Shimura T, Yamamoto M, Kagase A, Kodama A, Kano S, Koyama Y, Tada N, Takagi

K, Araki M, Yamanaka F, Shirai S, Watanabe Y, Hayashida K. The incidence,

predictive factors and prognosis of acute pulmonary complications after transcatheter

aortic valve implantation. Interact Cardiovasc Thorac Surg. 2017 Apr 26

author

: 17, 2

author: 15, last author: 14, corresponding author: 10)

Yüklə 198,24 Kb.

Dostları ilə paylaş: